ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Comparison of Simultaneous Pancreas kidney Transplantation to Kidney Transplantation Alone for Type 2 Diabetes with End Stage Renal Disease

Y. Fu, Z. Shen

Kidney&Pancreas Transplant, Tianjin First Center Hospital, Tianjin, China

Meeting: 2019 American Transplant Congress

Abstract number: D363

Keywords: Graft function, Kidney/pancreas transplantation, Metabolic complications, Survival

Session Information

Session Name: Poster Session D: Late Breaking

Session Type: Poster Session

Date: Tuesday, June 4, 2019

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

*Purpose: To compare the clinic outcomes of simultaneous pancreas-kidney transplantation (SPK) with kidney transplantation alone (KTA) in Type 2 Diabetes patients with ESRD.

*Methods: 97 type 2 diabetes atients with ESRD, among which 39 patients underwent SPK and 58 underwent KTA between May 2010 and May 2017 in our center, were retrospected. SPK were performed as Figure1. General demographic characters were compared between these two cohorts of patients. Pre operative as well as post transplantation profiles of overall survival rate, renal graft survival, plasma glucose, blood lipid, renal function and complications rate were also compared.All organs were from deceased citizen donors and none were prisoners in this study.

*Results: There is no significant difference of gender age,BMI, preoperative PRA average dialysis time between SPK group and KTA group. However, the hospitalization days were significantly varied between the two cohorts, with the median hospitalization day of SPK recipients as 41((29-57), longer than that of KTA recipients, 20.5(17-30.3) (p<0.001) (Figure 2). In addition, the immunosuppression agents were significantly different between two groups. Specifically, 94.9% SPK recipients were administrated polyclonal antibody as induction agents, while majority (63.8%) KTA recipients were administrated monoclonal antibody. FK accounted for 97.4% of immune maintaining agents in SPK group, significantly different from that in KTA group (37.9%)(Figure 3). The overall post transplantation survival rate of recipients (p=0.325) , renal graft (p=0.676) as well as complications of rejection (17.9% vs 15.5%, p=0.97), delayed graft function (7.7% vs 0%; p=0.122), and cerebral infarction (0% vs 6.9%, p=0.248) all did not vary significantly between SPK and KTA cohorts(Figure4). Nevertheless, the long term survival rate of renal graft was significantly better in SPK cohort than KTA cohort, with 7-year renal survival rate being 89.2% vs.70.5% (P=0.04) respectively (Figure 5,6) with the 7 years pancreas graft survival rate 80.6%. The hypertension (61.5% vs. 81%, p=0.03), coronary heart disease (2.6% vs 25.9%, p=0.002), and hyperlipidemia (23.1% vs. 50%, p=0.007) were significantly lower in SPK cohort than in KTA cohort. Plasma glucose were dropped significantly more followed transplantation in the first a couple of years in SPK cohort than in KTA cohort.

*Conclusions: SPK can improve long term renal graft survival rate and less metabolism complication of post transplanted hypertension and coronary heart disease in type 2 Diabetes patients with ESRD.

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Fu Y, Shen Z. Comparison of Simultaneous Pancreas kidney Transplantation to Kidney Transplantation Alone for Type 2 Diabetes with End Stage Renal Disease [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/comparison-of-simultaneous-pancreas-kidney-transplantation-to-kidney-transplantation-alone-for-type-2-diabetes-with-end-stage-renal-disease/. Accessed July 9, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences